Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Guidance on Alzheimer's drugs to benefit 100 000s

    • 8 Accesses

    • 1 Citations

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Guidance on Alzheimer's drugs to benefit 100 000s. Pharmacoecon. Outcomes News 614, 7 (2010). https://doi.org/10.2165/00151234-201006140-00013

    Download citation

    Keywords

    • Memantine
    • Rivastigmine
    • Galantamine
    • Chief Executive
    • Acetylcholinesterase Inhibitor